GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
49.82
-0.41 (-0.82%)
At close: Mar 9, 2026, 4:00 PM EDT
49.02
-0.80 (-1.61%)
After-hours: Mar 9, 2026, 4:39 PM EDT
GRAIL Employees
GRAIL had 1,000 employees as of December 31, 2024. The number of employees decreased by 360 or -26.47% compared to the previous year.
Employees
1,000
Change (1Y)
-360
Growth (1Y)
-26.47%
Revenue / Employee
$147,172
Profits / Employee
-$408,351
Market Cap
2.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000 | -360 | -26.47% |
| Dec 31, 2023 | 1,360 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,000 |
| Sotera Health Company | 3,000 |
| Neogen | 2,974 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
| CareDx | 765 |
GRAL News
- 4 days ago - Levi & Korskinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed - GlobeNewsWire
- 6 days ago - GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 12 days ago - GRAIL to Present at the TD Cowen 46th Annual Health Care Conference - PRNewsWire
- 14 days ago - GRAIL Stock Tumbles — National Health Service Galleri Trial To Blame - Benzinga
- 14 days ago - 'Holy Grail' Honus Wagner card sells for over $5M as family auctions it from grandfather's collection - Fox Business
- 16 days ago - This once-hot cancer-detection company's stock got cut in half after a failed trial - Market Watch
- 17 days ago - Grail shares plunge after major cancer screening trial misses main goal - Reuters
- 17 days ago - Grail Stock Plunges 50% After Earnings. But It's These Test Results That Are to Blame. - Barrons